Absolutely best possible outcome , adult trial is likely to get the green light too… resubmission and AA for LVAD… very interesting end of 2024 and start of 2025
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-73
-
- There are more pages in this discussion • 1,020 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.040(4.04%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.01 | 95.0¢ | $2.138M | 2.192M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 81447 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 123028 | 14 |
View Market Depth
| Last trade - 10.54am 01/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |